ArticleTargeted oncology2015
Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition.
Simona Coco et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this papercites it